During her tenure at the OIG, Meredith served in two distinct senior counsel roles that together span the full arc of federal healthcare oversight. For more than 16 years in the Industry Guidance Branch, she prepared OIG advisory opinions, drafted regulations, and issued public guidance addressing the legality of healthcare transactions and arrangements under the Anti-Kickback Statute (AKS), the Civil Monetary Penalties (CMP) law, and other federal fraud and abuse authorities. She also designed fraud and abuse waivers for Center for Medicare and Medicaid Innovation (CMMI) payment models to support coordinated care initiatives — work that placed her at the forefront of federal efforts to modernize healthcare delivery.

At OIG, Meredith also served in the Administrative and Civil Remedies Branch, where she worked closely with DOJ to investigate and resolve major False Claims Act cases involving AKS violations and Medicare and Medicaid reimbursement fraud. She monitored compliance by healthcare entities with their obligations under Corporate Integrity Agreements (CIAs). Her work encompassed the full lifecycle of compliance program oversight: risk assessment, policy development, remediation, self-disclosure, and direct engagement with senior leadership, boards of directors, and government regulators at HHS and OIG.

Prior to joining the OIG, Meredith practiced healthcare law in private practice, advising clients on the same federal fraud and abuse framework she would later help shape from within the government. That foundation, combined with her government career, gives her an unusually complete view of how enforcement priorities are set, how guidance is developed, and how regulated entities can most effectively respond.

At Barnes & Thornburg, Meredith draws on this dual perspective to counsel life sciences companies, hospitals and health systems, physicians, ambulatory surgery centers, accountable care organizations, and pharmacies. She designs compliant commercial arrangements and joint ventures, advises on healthcare mergers and acquisitions, guides clients through and ongoing post-settlement compliance, and serves as a Compliance Expert and Legal Independent Review Organization (IRO) under CIAs. She is a trusted advisor to boards and C-suite executives on strategic decisions involving investigations, compliance oversight, healthcare transactions, and self-disclosures.